{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:02:20Z","timestamp":1791514940561,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013220","name":"Ultragenyx Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013220","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ymgme.2020.02.009","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T21:50:49Z","timestamp":1583445049000},"page":"65-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Vestronidase alfa: Recombinant human \u03b2-glucuronidase as an enzyme replacement therapy for MPS VII"],"prefix":"10.1016","volume":"130","author":[{"given":"Jaclyn","family":"Cadaoas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Jungles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Vellard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Grubb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Jurecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Sly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Kakkis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ymgme.2020.02.009_bb0005","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0021-9258(18)71060-0","article-title":"Enzymatic formation of monosaccharides from hyaluronate","volume":"213","author":"Linker","year":"1955","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.009_bb0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0022-3476(73)80162-3","article-title":"Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis","volume":"82","author":"Sly","year":"1973","journal-title":"J.Pediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2020.02.009_bb0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jmedgenet-2015-103322","article-title":"Clinical course of sly syndrome (mucopolysaccharidosis type VII)","volume":"53","author":"Montano","year":"2016","journal-title":"J. Med. Genet."},{"issue":"6","key":"10.1016\/j.ymgme.2020.02.009_bb0020","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1203\/00006450-199606000-00019","article-title":"Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival","volume":"39","author":"Vogler","year":"1996","journal-title":"Pediatr. Res."},{"issue":"41","key":"10.1016\/j.ymgme.2020.02.009_bb0025","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.1073\/pnas.0506892102","article-title":"Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII","volume":"102","author":"Vogler","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.ymgme.2020.02.009_bb0030","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1172\/JCI1773","article-title":"Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function","volume":"101","author":"O\u2019Connor","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.ymgme.2020.02.009_bb0035","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1172\/JCI117237","article-title":"Enzyme replacement therapy for murine mucopolysaccharidosis type VII","volume":"93","author":"Sands","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.ymgme.2020.02.009_bb0040","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1517\/21678707.2013.780970","article-title":"Emerging therapies and therapeutic concepts for lysosomal storage diseases","volume":"1","author":"Kirkegaard","year":"2013","journal-title":"Expert Opinion on Orphan Drugs"},{"key":"10.1016\/j.ymgme.2020.02.009_bb0045","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-med-122313-085916","article-title":"Lysosomal storage diseases: from pathophysiology to therapy","volume":"66","author":"Parenti","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"7","key":"10.1016\/j.ymgme.2020.02.009_bb0050","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1073\/pnas.0712147105","article-title":"Chemically modified beta-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII","volume":"105","author":"Grubb","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"3","key":"10.1016\/j.ymgme.2020.02.009_bb0055","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1073\/pnas.84.3.685","article-title":"Cloning, sequencing, and expression of cDNA for human beta-glucuronidase","volume":"84","author":"Oshima","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"10","key":"10.1016\/j.ymgme.2020.02.009_bb0060","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1002\/jps.21684","article-title":"Increasing the sialylation of therapeutic glycoproteins: the potential of the sialic acid biosynthetic pathway","volume":"98","author":"Bork","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ymgme.2020.02.009_bb0065","series-title":"Mepsevii [package insert]","year":"2017"},{"issue":"9","key":"10.1016\/j.ymgme.2020.02.009_bb0070","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1073\/pnas.76.9.4322","article-title":"Enzymatic identification of mannose 6-phosphate on the recognition marker for receptor-mediated pinocytosis of beta-glucuronidase by human fibroblasts","volume":"76","author":"Natowicz","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ymgme.2020.02.009_bb0075","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/bst0180367","article-title":"Lysosomal enzyme targeting","volume":"18","author":"Kornfeld","year":"1990","journal-title":"Biochem. Soc. Trans."},{"issue":"3","key":"10.1016\/j.ymgme.2020.02.009_bb0080","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/prep.1994.1035","article-title":"Overexpression of the human lysosomal enzyme alpha-L-iduronidase in Chinese hamster ovary cells","volume":"5","author":"Kakkis","year":"1994","journal-title":"Protein Expr. Purif."},{"issue":"3","key":"10.1016\/j.ymgme.2020.02.009_bb0085","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/bit.1051","article-title":"Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells","volume":"73","author":"Baker","year":"2001","journal-title":"Biotechnol. Bioeng."},{"issue":"26","key":"10.1016\/j.ymgme.2020.02.009_bb0090","doi-asserted-by":"crossref","first-page":"12937","DOI":"10.1073\/pnas.91.26.12937","article-title":"Enzyme replacement in a canine model of hurler syndrome","volume":"91","author":"Shull","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.ymgme.2020.02.009_bb0095","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1073\/pnas.051623698","article-title":"Active site mutant transgene confers tolerance to human beta-glucuronidase without affecting the phenotype of MPS VII mice","volume":"98","author":"Sly","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.009_bb0100","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/mgme.1999.2894","article-title":"Immune response to enzyme replacement therapy in lysosomal storage disorder patients and animal models","volume":"68","author":"Brooks","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.02.009_bb0105","series-title":"10th Annual World Lysosomal Disease Network Symposium, San Diego, CA, Feb 13, 2014","article-title":"Recombinant Human Beta-Glucuronidase Enzyme Replacement Therapy for Mucopolysaccharidosis Type 7: Report of the First Patient Treated. Oral Presentation","author":"Fox","year":"2014"},{"key":"10.1016\/j.ymgme.2020.02.009_bb0110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ymgme.2014.10.017","article-title":"First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient","volume":"114","author":"Fox","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2020.02.009_bb0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nchembio.766","article-title":"Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidoses","volume":"8","author":"Lawrence","year":"2012","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.ymgme.2020.02.009_bb0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2010.09.003","article-title":"Efficient analysis of urinary glycosaminoglycans by LC-MS\/MS in mucopolysaccharidoses type I, II and VI","volume":"102","author":"Auray-Blais","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2020.02.009_bb0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5483\/BMBRep.2013.46.3.192","article-title":"Enhanced sialylation and in vivo efficacy of recombinant human alpha-galactosidase through in vitro glycosylation","volume":"46","author":"Sohn","year":"2013","journal-title":"BMB Rep."},{"issue":"5","key":"10.1016\/j.ymgme.2020.02.009_bb0130","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0021-9258(19)76994-4","article-title":"The role of sialic acid in determining the survival of glycoproteins in the circulation","volume":"246","author":"Morell","year":"1971","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ymgme.2020.02.009_bb0135","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/jps.21504","article-title":"Effects of glycosylation on the stability of protein pharmaceuticals","volume":"98","author":"Sola","year":"2009","journal-title":"J. Pharm. Sci."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220300597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220300597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:25:48Z","timestamp":1761089148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719220300597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1096719220300597"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.02.009","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vestronidase alfa: Recombinant human \u03b2-glucuronidase as an enzyme replacement therapy for MPS VII","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}